These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21251863)

  • 1. Role for interferon-gamma release assays in latent tuberculosis screening before TNF-α antagonist therapy.
    Lioté H; Lioté F
    Joint Bone Spine; 2011 Jul; 78(4):352-7. PubMed ID: 21251863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
    Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
    J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
    Martin J; Walsh C; Gibbs A; McDonnell T; Fearon U; Keane J; Codd MB; Dodd J; Veale D; Fitzgerald O; Bresnihan B
    Ann Rheum Dis; 2010 Jan; 69(1):181-5. PubMed ID: 19176545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
    Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
    Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for latent tuberculosis infection in immunosuppressed patients not infected with HIV].
    Vongthilath R; Gasche-Soccal P; Roux-Lombard P; Janssens JP
    Rev Med Suisse; 2019 Nov; 15(671):2105-2108. PubMed ID: 31742942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis screening before biologic therapy. Comment about the article entitled "role for interferon-gamma release assays in latent tuberculosis screening before TNF-α antagonist therapy" by Liote H et al.
    Mrozek N; Pereira B; Dubost JJ; Soubrier M
    Joint Bone Spine; 2011 Dec; 78(6):655-6; author reply 656-7. PubMed ID: 21924937
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
    Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
    Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
    Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults.
    Redelman-Sidi G; Sepkowitz KA
    Am J Respir Crit Care Med; 2013 Aug; 188(4):422-31. PubMed ID: 23262514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
    Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
    Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
    Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
    Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.
    Cantini F; Lubrano E; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A
    Int J Rheum Dis; 2016 Aug; 19(8):799-805. PubMed ID: 26172207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.
    Menzies D; Pai M; Comstock G
    Ann Intern Med; 2007 Mar; 146(5):340-54. PubMed ID: 17339619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for tuberculosis infection prior to medical therapy].
    Ravn P
    Ugeskr Laeger; 2011 Mar; 173(12):893-6. PubMed ID: 21419060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
    Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
    Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.